5-氨基乙酰丙酸诱导荧光引导切除联合术中开放式光动力治疗复发胶质母细胞瘤:局部肿瘤控制双重策略的病例系列
该病例系列纳入20例复发高级别胶质瘤患者,在5-氨基乙酰丙酸荧光引导切除后于瘤腔内行60分钟光动力治疗。术后6个月仅1例手术部位感染,16例(80%)出现切除缘细胞毒性水肿,中位无进展生存期6个月(95%CI 4.8-7.2个月),作者认为该联合策略安全且无进展生存期令人鼓舞。
要点
- 20例复发高级别胶质瘤接受5-氨基乙酰丙酸荧光引导切除联合术中光动力治疗。
- 术后6个月仅1例手术部位感染,为主要不良事件。
- 中位无进展生存期6个月(95%CI 4.8-7.2个月)。
核心结论
- 5-氨基乙酰丙酸荧光引导切除联合光动力治疗提供了一种创新且安全的局部肿瘤控制方法,无进展生存期令人鼓舞。
- 作者认为需进一步前瞻性研究评估长期治疗效果。
研究设计与样本
- 病例系列,纳入20例复发高级别胶质瘤患者。
- 在5-氨基乙酰丙酸荧光引导切除后,将激光扩散器置于切除腔内,行光动力治疗60分钟(635 nm,200 mW/cm扩散器,持续1小时),期间持续冲洗保持光学清晰并通100%氧气。
- 术后24小时、14天及每3个月行MRI,包括弥散张量成像和表观弥散系数图。
主要发现
- 20例中16例(80%)MRI显示切除缘细胞毒性水肿,多呈环状围绕瘤腔,对应先前激光扩散器位置(平均体积3.3 cm3)。
- 水肿似乎选择性出现在浸润组织或未切除的强化肿瘤区域。
- 14天随访时,原水肿区域出现强化,部分病例在4-5个月后强化消失。
- 中位无进展生存期为6个月(95%CI 4.8-7.2个月)。
- 术后6个月仅1例手术部位感染,为唯一不良事件。
临床怎么用
- 作者认为该联合策略安全且无进展生存期令人鼓舞,但需进一步前瞻性研究评估长期疗效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: High-grade glioma (HGG) prognosis remains dismal, with inevitable, mostly local recurrence. Regimens for improving local tumor control are therefore needed. Photodynamic therapy (PDT) using porfimer sodium has been investigated but was abandoned due to side effects and lack of survival benefits. Intracellular porphyrins induced by 5-aminolevulinic acid (5-ALA) are approved for fluorescence-guided resections (FGRs), but are also photosensitizers. Activated by light, they generate reactive oxygen species with resultant cytotoxicity. The authors present a combined approach of 5-ALA FGR and PDT. METHODS: After 5-ALA FGR in recurrent HGG, laser diffusors were strategically positioned inside the resection cavity. PDT was applied for 60 minutes (635 nm, 200 mW/cm diffusor, for 1 hour) under continuous irrigation for maintaining optical clarity and ventilation with 100% oxygen. MRI was performed at 24 hours, 14 days, and every 3 months after surgery, including diffusion tensor imaging and apparent diffusion coefficient maps. RESULTS: Twenty patients were treated. One surgical site infection after treatment was noted at 6 months as the only adverse event. MRI revealed cytotoxic edema along resection margins in 16 (80%) of 20 cases, mostly annular around the cavity, corresponding to prior laser diffusor locations (mean volume 3.3 cm3). Edema appeared selective for infiltrated tissue or nonresected enhancing tumor. At the 14-day follow-up, enhancement developed in former regions of edema, in some cases vanishing after 4-5 months. Median progression-free survival (PFS) was 6 months (95% CI 4.8-7.2 months). CONCLUSIONS: Combined 5-ALA FGR and PDT provides an innovative and safe method of local tumor control resulting in promising PFS. Further prospective studies are warranted to evaluate long-term therapeutic effects.
引用
- Schipmann S, Müther M, Stögbauer L, et al. Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control. J Neurosurg. 2020. PMID: 31978877. doi:10.3171/2019.11.JNS192443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。